Try searching by key words, order- or product code or serial number e.g. “CM442” or “Technical information”
Enter at least 2 characters to start the search.

Meeting the requirements of biopharmaceutical processes

Managing highly specific manufacturing requirements and complex products

biopharmaceutical manufacturing plant with biopharmaceutical processing

The last decade saw the rise of the biopharmaceutical industry and the fast adoption of biological products. The industry carries a wide range of products, from vaccines to personalized therapies or targeted products and specialty medicines for many orphan diseases. The industry had to pivot from a traditional model of processing block-buster compounds to limited biopharmaceutical production runs and specific manufacturing requirements to cater to these products.

Key facts

12 years

The average time it takes to develop a drug

Medical autoclaves performing sterilization at elevated temperatures using saturated steam ©Endress+Hauser
Insights

Equipment sterilization in medical autoclaves

Medical autoclaves rely on precise and reliable temperature measurements to comply with process requirements. New sensor technology automates recalibrations, reducing risk between intervals and providing audit-proof batch certification.

Our expertise in the field

Self-calibrating temperature measurement technology can minimize the risk of incorrect measurements and improve process safety and regulatory compliance (FDA) in pharmaceutical applications with continuous process verification (GMP). Automated documentation helps effortlessly build a repeatable, traceable record database for audits and regulatory authorities.

  • The self-calibrating hygienic iTHERM TrustSens TM371 lowers risk and drives automation in regulated processes with fully automated process documentation and built-in memory for 350 calibration events.
  • The Heartbeat Technology offers full instrument diagnostics, monitoring and verification, effectively eliminating the risk of undetected non-conformities.
Instrumentation designed according to ASME-BPE guidance ©Endress+Hauser
Insights

Instrumentation designed according to ASME-BPE

The ASME-BPE has brought some degree of standardization to the equipment used in biopharmaceutical processing and includes best-practices for enhancing product purity and safety while maintaining high levels of hygiene. Reflecting the innovative nature of the industry, it is reviewed regularly. Companies that rigorously apply ASME-BPE can often achieve higher production efficiencies, lower development and manufacturing costs, and increase quality and safety, while complying with regulations.

Our expertise in the field

For a system or component to be ASME BPE-compliant, adherence to all applicable parts of the standard is required. The stringent requirements of BPE often mean that only devices specifically designed according to standard can achieve full compliance. Endress+Hauser offers a complete portfolio of instruments that are designed and manufactured according to ASME BPE, such as:

Bioreactor in a biopharmaceutical manufacturing plant ©Endress+Hauser
Insights

Advanced analytics for process control in bioreactors

In a bioreactor, it is essential to keep the dissolved oxygen and pH at an optimal level at all times. Cell density and metabolites should also be monitored for a better insight into the process. The concentration of metabolites is typically measured off-line with time-consuming techniques and therefore requires sampling with the associated risks.

Our expertise in the field

Raman spectroscopy is an ideal solution for fast and non-destructive measurement. Our Raman solutions can monitor several parameters simultaneously with one single probe installed directly in-line. The complete upstream package enables real-time and optimized control of the process leading to reduced time between batches, limited risk of contamination and increased yield.

Benefits

From our ASME-BPE compliant portfolio to our advanced analytical technology and calibration services, we are committed to helping you improve your biopharmaceutical manufacturing process, getting your product to market faster while safeguarding product quality and mitigating risk.

Key facts

35

fermentation batches until ROI of a single channel Kaiser Raman Rxn system

Key facts

2 months

faster time to market when streamlining your projects for the biopharmaceutical manufacturing processes together with our industry experts

Key facts

10%

cost reduction thanks to preventive maintenance concepts

Takeaway

How we can help

Endress+Hauser is committed to addressing the challenges of the biopharmaceutical industry. By integrating consistent and comparable data with our measurement technology, we enable the rapid detection of process changes and therefore warrant consistent quality attributes of your product. With our complete portfolio that meets the biopharmaceutical industry standards, we support you in releasing your product to the market faster while safeguarding high-quality attributes.

  • Complete ASME BPE-compliant instrument portfolio that accurately monitors critical process conditions from lab to process.
  • Full solutions specially designed for biopharmaceutical manufacturing, including Process Analytical Technology (PAT) for real-time control and optimization.
  • Expert consulting in process scale-up from pilot to automated production units.
  • Calibration services and predictive maintenance that ensure full compliance with minimal interruptions.
  • Expertise in project planning and engineering, facilitating plant setup with early standardization.

Endnotes

Related articles

Discover more interesting articles